CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland - New Report Available

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland". The report, an essential source of information and analysis, identifies key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscapes and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. This resource has been produced using data and information from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2013, Poland's population was estimated at 38.5 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.2% from 2008. It is however expected to decrease to approximately 38.4 million by 2020 due to a drop in the birth rate. The value of the pharmaceutical market in the country amounted to $8.6 billion in 2013, and it is expected to increase at a CAGR of 8.3% to approximately $15 billion in 2020. Generics accounted for the majority of the market in 2012 with a share of 66%.

Full Report Details at
- http://www.fastmr.com/prod/871824_countryfocus_healthcare_regulatory_and.aspx?afid=301

This positive trend can be attributed primarily to the following factors -

* Government initiatives and support from the EU to improve healthcare services
* An improved and updated regulatory environment

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Poland, including the following -

* An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
* Profiles and SWOT analyses for the major players in the pharmaceutical market (Sanofi, Novartis, GlaxoSmithKline, Polpharma and F. Hoffmann-La Roche)
* Profiles and SWOT analyses for the major players in the medical device market (F. Hoffmann-La Roche, Medtronic, Essilor International, Abbott Laboratories and Siemens Healthcare)
* An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
* Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
* An overview of the opportunities for and challenges facing growth in the healthcare market

Reasons to Get this Report

This report will enhance your decision-making capability by allowing you to -

* Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in Poland

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey